Mr
Bernhard
Ganahl

Partner & Patent Attorney

Munich Office Salzburg Office

Electronics

Telephone. +49(0) 891 259 9600
Mobile. +49(0) 160 357 0500
Email. [email protected]

Experience

Bernhard's main focus lies in the drafting and handling of patents in the areas of electric engineering, software inventions as well as devices for biotechnology and optics. Furthermore he possesses great experience in opposition cases and IP litigation cases as well as trade mark protection.

Bernhard studied Applied Physics at the Technical University of Munich. He has been in the IP business since 1990. He was accredited as a German Patent Attorney in 1994 and in the same year also qualified as a European Patent Attorney.

He has made his name as a specialist legal author with, amongst others, with the article “Patent situation in the field of DNA chip technology in Europe” (which appeared in no. 12/2000 of medgen, the journal of the German Association for Human Genetics) and the articles “Is the core theory once again topical?” (which appeared in the Transactions of German Patent Attorneys in December 2003) and "G 1/19: Did this decision surprise us?" (which appeared in the Transactions of German Patent Attorneys in December 2019), both dealing with German case law in respect of software inventions. The first article was cited by the Enlarged Board of Appeal in the fundamental decision (G 03/08) relating to computer implemented inventions. He regularly gives lectures on different topics in IP law.

Bernhard is a member of the Licensing Executive Society (LES), GRUR and the European Patent Experts Exchange (EuPEX).

Qualifications

Patent Attorney

Austria
Europe
Germany

Trade Mark Attorney

Austria
Europe
Germany


OTHER

Dipl. Phys.

Publications

IAM Global Patent Prosecution 2023

View publication online

G 1/19: Did this decision surprise us?

View publication online

IAM Patent 1000 2022

View publication online

From March 1 Patronus IP have merged with HGF

View publication online

G1/19: EPO oral proceedings

View publication online

G1/19: Did this decision surprise us?

Conferences: 2022

November 10th 2022

Webinar: basics and news about Unified Patent Court

Speaker

Event details

October 31st 2022

IPBC Asia

Attended

Event details

October 15th 2022

APAA 2022

Attended

Event details

May 10th 2022

HGF UPC events in Germany and Austria 2022

Speaker

Event details

Conferences: 2021

October 29th 2021

APAA 2021

Attended

Event details

Conferences: 2020

July 15th 2020

G1 19 hearing at the EPO

Attended

Event details

Related News

Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Parallel importation of pharmaceuticals – when is repackaging necessary?

The repackaging of pharmaceutical products by parallel importers is a long debated subject. The above question was reconsidered in a set of judgements by the CJEU in November last year …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

Trade mark protection for digital health products

The use and creation of digital healthcare products is on the rise as companies look to create a unique selling point and a differentiator in a crowded market. One of …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.